Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease (2023)
- Authors:
- Rezende Junior, Celso de Oliveira

- Martinez, Pablo David Grigol
- Ferreira, Rafael Augusto Alves
- Koovits, Paul John

- Soares, Bruna Miranda

- Ferreira, Leonardo Luiz Gomes

- Duarte, Simone Michelan

- Chelucci, Rafael Consolin
- Andricopulo, Adriano Defini

- Matheeussen, An

- Van Pelt, Natascha
- Caljon, Guy

- Maes, Louis

- Campbell, Simon
- Kratz, Jadel Muller

- Mowbray, Charles E.

- Dias, Luiz Carlos

- Rezende Junior, Celso de Oliveira
- USP affiliated authors: FERREIRA, LEONARDO LUIZ GOMES - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; DUARTE, SIMONE MICHELAN - IFSC ; CHELUCCI, RAFAEL CONSOLIN - IFSC
- Unidade: IFSC
- DOI: 10.1016/j.ejmech.2022.114925
- Subjects: DOENÇA DE CHAGAS; PLANEJAMENTO DE FÁRMACOS; TRYPANOSOMA CRUZI
- Keywords: 2-Aminobenzimidazole derivatives; Chagas disease; Hit-to-lead; Multiparametric optimization; Trypanosoma cruzi
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Issy-les-Moulineaux
- Date published: 2023
- Source:
- Título: European Journal of Medicinal Chemistry
- ISSN: 0223-5234
- Volume/Número/Paginação/Ano: v. 246, p. 114925-1-114925-10 + supplementary data, Jan. 2023
- Status:
- Artigo aberto em periódico híbrido (Hybrid Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
REZENDE JUNIOR, Celso de Oliveira et al. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease. European Journal of Medicinal Chemistry, v. 246, n. Ja 2023, p. 114925-1-114925-10 + supplementary data, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2022.114925. Acesso em: 31 mar. 2026. -
APA
Rezende Junior, C. de O., Martinez, P. D. G., Ferreira, R. A. A., Koovits, P. J., Soares, B. M., Ferreira, L. L. G., et al. (2023). Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease. European Journal of Medicinal Chemistry, 246( Ja 2023), 114925-1-114925-10 + supplementary data. doi:10.1016/j.ejmech.2022.114925 -
NLM
Rezende Junior C de O, Martinez PDG, Ferreira RAA, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Matheeussen A, Van Pelt N, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease [Internet]. European Journal of Medicinal Chemistry. 2023 ; 246( Ja 2023): 114925-1-114925-10 + supplementary data.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114925 -
Vancouver
Rezende Junior C de O, Martinez PDG, Ferreira RAA, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Matheeussen A, Van Pelt N, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease [Internet]. European Journal of Medicinal Chemistry. 2023 ; 246( Ja 2023): 114925-1-114925-10 + supplementary data.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114925 - Novel deferasirox analogues designed as iron chelating agents for iron overload treatment
- Optimized HDAC inhibitors induce robust γ-globin gene expression and exhibit superior efficacy to hydroxyurea in Sickle Cell Disease models
- Discovery of arylpiperazines with broad-spectrum antimicrobial activity and favorable pharmacokinetic profiles
- Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum
- Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
- Convergent synthesis of proline-functionalized pyrazolopyrimidines as anti-T. cruzi bioactive compounds
- Indoles hit-to-lead for chagas disease: lessons learned within the LOLA consortium
- Design, synthesis and in vitro evaluation of a series of arylmorpholine derivative compounds against chagas disease
- Design and synthesis of boronic chalcones with dual anticancer and anti-inflammatory activity
- Potente reativação da produção de hemoglobina fetal por novo inibidor seletivo de histona deacetilase 1 e 2
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
| PROD033848_3114523.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
